Ticker ALXN – Alexion – sales, description, marketcap – Tickerday.com

ALXN

Alexion

–

Index: NASDAQ; Sector: Healthcare; Industry: Major Drugs;

Marketcap: 24.85B; Volume: 476.54K; AvgVol 3m: 1.85M; Beta: 1.35;

Cost estimate:

P/E: 30.13; EPS: 3.73; EPS growth quarter/prev quarter: -337.60%;

EPS growth this year: 4.50%; EPS growth past 5 years: 26.80%;

EPS ttm: 3.73;

P/S: 4.76; P/B: 2.44; P/Cashflow: 9.25; P/FCF: 11.15;

Sales: 5.54B; Sales growth quarter/prev quarter: 20.10%; Sales growth past 5 years: 17.40%;

Profitability:

Gross Margin: 91.60%; Profit Margin: 15.30%; Operating Margin: 7.20%;

ROA – return on assets: 5.00%; ROE – return on equity: 7.70%; LT Debt/Equity: 0.22; Total Debt/Equity: 0.23;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.10%; Insider Transactions:-2.93%;

Institutional Ownership: 93.60%; Institutional Transactions: -0.39%;

Data update: 07.10.2020.